Cleared Traditional

K942073 - SHARPSPRO-TECTOR

K942073 is an FDA 510(k) clearance for SHARPSPRO-TECTOR, manufactured by Superior Diapering Products , Ltd.. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 671-day FDA review.

K942073 · Superior Diapering Products , Ltd. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1996
Decision
671d
Days
Class 2
Risk

K942073 is an FDA 510(k) clearance for the SHARPSPRO-TECTOR. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Superior Diapering Products , Ltd. (Point Roberts, US). The FDA issued a Cleared decision on February 29, 1996 after a review of 671 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all Superior Diapering Products , Ltd. devices

FDA 510(k) Submission Details - K942073

510(k) Number K942073 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 29, 1994
Decision Date February 29, 1996
Days to Decision 671 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
542d slower than avg
Panel avg: 129d · This submission: 671d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 405
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K942073.
CORD WRAP WITH NEEDLE RESHEATHER
K960963 · Osborn Medical Corp. · May 1996
NON-CORING NEEDLE
K960698 · Med Institute, Inc. · Apr 1996
DOYLE EXTRACTOR
K955748 · Safetech Intl., Inc. · Mar 1996
INSULCAP
K952044 · Karen Holtz · Feb 1996
B-D ULTRA FINE II, MICRO FINE + SHORT NEEDLE INSULIN SYRINGE
K955235 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Feb 1996
DARWIN HYPODERMIC SAFETY SYSTEM (DHSS)
K952837 · Emk Enterprises, LLC · Jan 1996